48 results on '"Zheng, Zizheng"'
Search Results
2. Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages
3. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
4. Prophylactic Hepatitis E Vaccine
5. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
6. Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection
7. The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations
8. Viral neutralization by antibody-imposed physical disruption
9. Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant
10. Serological Evidence of Hepatitis E Virus (HEV) from a Multi-ethnic Study of Asian men (The Subang Men’s Health Study)
11. Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection
12. Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency
13. Urine is a viral antigen reservoir in hepatitis E virus infection
14. Virus-mimetic nanovesicles as a versatile antigen-delivery system
15. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses
16. Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient
17. Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response
18. A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity
19. Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
20. Serological Evidence of Hepatitis E Virus (HEV) Infection Among Ruminant Farmworkers: A Retrospective Study from Malaysia
21. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
22. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes
23. Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
24. Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
25. Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
26. A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity
27. The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations
28. Quantatitive Analysis of Conserved Sites on the SARS-CoV-2 Receptor-Binding Domain to Promote Development of Universal SARS-Like Coronavirus Vaccines
29. Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78
30. Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing
31. Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent
32. The study of seroprevalence of hepatitis E virus and an investigation into the lifestyle behaviours of the aborigines in Malaysia
33. Development and evaluation of a rapid point-of-care test for detecting the hepatitis E virus antigen
34. Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A
35. Vesicular Antibodies: A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy
36. An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2
37. Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine
38. The ORF3 Protein of Genotype 1 Hepatitis E Virus Suppresses TLR3-induced NF-κB Signaling via TRADD and RIP1
39. Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment
40. Open Reading Frame 3 of Genotype 1 Hepatitis E Virus Inhibits Nuclear Factor-κappa B Signaling Induced by Tumor Necrosis Factor-α in Human A549 Lung Epithelial Cells
41. Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78
42. Putative receptor-binding sites of hepatitis E virus
43. Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China.
44. Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus.
45. [Preparation and identification of mouse anti-human monoclonal antibody against P protein of respiratory syncytial virus].
46. [Comparison of Respiratory Syncytial Virus Infection on Different Week-ages BALB/c Mice].
47. [Research Progress in Laboratory Diagnostic Methods for HEV Infection].
48. [The establishment of high-throughput neutralization titer evaluation model for hepatitis E virus (HEV)].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.